title: Protection against inhalation toxicity of ricin and abrin by immunisation.
abstract: 1. Abrin and ricin are highly toxic plant proteins which are very similar in structure and function and inhibit protein synthesis in eukaryotes. 2. Rats have been immunised against either toxin using formaldehyde-toxoids by three subcutaneous injections at intervals of 3 weeks. For abrin, serum titres in 14 out of 15 rats were raised to between 1:12800 and 1:51200 after two injections, 6 weeks from the start of the experiment. Titres of between 1:256 and 1:1024 were also measured in lung washes after challenge with active abrin toxin. 3. The three major antibody classes, IgG, IgM and IgA were present in the immune sera but IgG and IgA only were detected in lung washes. The proportion of IgA to IgG was higher in the lung fluid than in sera. Rats immunised by abrin toxoid were protected against 5 LCt50's of abrin by inhalation but others exposed to ricin were not. 4. For ricin, serum titres ranged from 1:800 to 1:25600 after two injections and after a third injection the titre range was the same but population samples were weighted towards the higher titres. All rats immunised with ricin toxoid survived the challenge of 5 LCt50's of ricin toxin by inhalation over the observation period of 28 days post-challenge. 5. Representative immunised rats (abrin toxoid) were taken at various times post-exposure, humanely killed and tissues were examined for pathological changes. It was concluded that an apparently severe lung lesion occurred at a later time than in non-immunised, toxin challenged rats. This damage was not lethal over the experimental observation periods. 6. Immunisation by the sub-cutaneous route therefore protects against lethality from challenge by inhalation of ricin or abrin toxins but does not prevent significant lung damage.
authors.affiliation: Biology Division, Chemical & Biological Defence Establishment, Porton Down, Wiltshire, UK.
authors.forename: G D
authors.initials: GD
authors.lastname: Griffiths
authors.forename: C D
authors.initials: CD
authors.lastname: Lindsay
authors.forename: A C
authors.initials: AC
authors.lastname: Allenby
authors.forename: S C
authors.initials: SC
authors.lastname: Bailey
authors.forename: J W
authors.initials: JW
authors.lastname: Scawin
authors.forename: P
authors.initials: P
authors.lastname: Rice
authors.forename: D G
authors.initials: DG
authors.lastname: Upshall
mesh_terms: D000036:Abrin / Q000008:administration & dosage / Q000633:toxicity*; D000280:Administration, Inhalation; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D005557:Formaldehyde / Q000494:pharmacology; D007114:Immunization; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007279:Injections, Subcutaneous; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008171:Lung Diseases / Q000139:chemically induced / Q000517:prevention & control*; D008297:Male; D016612:Paraffin Embedding; D051381:Rats; D012276:Ricin / Q000008:administration & dosage / Q000633:toxicity*; D014121:Toxoids / Q000627:therapeutic use*
chemical_list: D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D014121:Toxoids; D000036:Abrin; D005557:Formaldehyde; D012276:Ricin